Recalibrating the risks and benefits of lithium therapy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28673941.
- Also identified by DOI 10.1192/bjp.bp.116.193789.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this <i>Journal</i>, a surprising reduction in the risk of cancer.
Medical subject headings
- Dementia
- Lithium Compounds
- Neoplasms